|Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma|
WR Jarnagin, Y Fong, RP DeMatteo, M Gonen, EC Burke, J Bodniewicz, ...
Annals of surgery 234 (4), 507, 2001
|DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors|
Y Jiao, C Shi, BH Edil, RF De Wilde, DS Klimstra, A Maitra, RD Schulick, ...
Science 331 (6021), 1199-1203, 2011
|Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry|
KY Chung, J Shia, NE Kemeny, M Shah, GK Schwartz, A Tse, A Hamilton, ...
Journal of clinical oncology 23 (9), 1803-1810, 2005
|Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions|
RH Hruban, NV Adsay, J Albores–Saavedra, C Compton, ES Garrett, ...
The American journal of surgical pathology 25 (5), 579-586, 2001
|The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems|
DS Klimstra, IR Modlin, D Coppola, RV Lloyd, S Suster
Pancreas 39 (6), 707-712, 2010
|An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms|
RH Hruban, K Takaori, DS Klimstra, NV Adsay, J Albores-Saavedra, ...
The American journal of surgical pathology 28 (8), 977-987, 2004
|Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients|
A Zehir, R Benayed, RH Shah, A Syed, S Middha, HR Kim, P Srinivasan, ...
Nature medicine 23 (6), 703, 2017
|Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors.|
KC Conlon, DS Klimstra, MF Brennan
Annals of surgery 223 (3), 273, 1996
|Organoid models of human and mouse ductal pancreatic cancer|
SF Boj, CI Hwang, LA Baker, IIC Chio, DD Engle, V Corbo, M Jager, ...
Cell 160 (1-2), 324-338, 2015
|Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC|
SJ Laken, GM Petersen, SB Gruber, C Oddoux, H Ostrer, FM Giardiello, ...
Nature genetics 17 (1), 79-83, 1997
|Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study|
T Furukawa, G Klöppel, NV Adsay, J Albores-Saavedra, N Fukushima, ...
Virchows Archiv 447 (5), 794-799, 2005
|Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection|
I Endo, M Gonen, AC Yopp, KM Dalal, Q Zhou, D Klimstra, M D'Angelica, ...
Annals of surgery 248 (1), 84-96, 2008
|Solid-pseudopapillary tumor of the pancreas: a surgical enigma?|
RCG Martin, DS Klimstra, MF Brennan, KC Conlon
Annals of Surgical Oncology 9 (1), 35-40, 2002
|Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes|
GH Fisher, SL Wellen, D Klimstra, JM Lenczowski, JW Tichelaar, MJ Lizak, ...
Genes & development 15 (24), 3249-3262, 2001
|NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas|
MH Kulke, LB Anthony, DL Bushnell, WW De Herder, SJ Goldsmith, ...
Pancreas 39 (6), 735, 2010
|Distinct roles for cysteine cathepsin genes in multistage tumorigenesis|
V Gocheva, W Zeng, D Ke, D Klimstra, T Reinheckel, C Peters, ...
Genes & development 20 (5), 543-556, 2006
|Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor β-catenin mutations|
SC Abraham, DS Klimstra, RE Wilentz, CJ Yeo, K Conlon, M Brennan, ...
The American journal of pathology 160 (4), 1361-1369, 2002
|Solid-pseudopapillary tumor of the pancreas: a typically cystic carcinoma of low malignant potential.|
DS Klimstra, BM Wenig, CS Heffess
Seminars in diagnostic pathology 17 (1), 66-80, 2000
|Acinar cell carcinoma of the pancreas. A clinicopathologic study of 28 cases.|
DS Klimstra, CS Heffess, JE Oertel, J Rosai
The American journal of surgical pathology 16 (9), 815-837, 1992
|Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict …|
V Rusch, D Klimstra, E Venkatraman, PW Pisters, J Langenfeld, ...
Clinical Cancer Research 3 (4), 515-522, 1997